A new multi-institutional study led by researchers at Michigan State University has characterized how fungi adapt to restructure their cell walls, effectively thwarting current antifungal medications.

Mandimycin is part of the family of glycosylated polyene macrolides that has provided many antifungal drugs, including AmB, nystatin and natamycin. Fungal resistance to these drugs is rare ...